Kings brief interstitial lung disease questionnaire: Responsiveness and minimum clinically important difference

File Description SizeFormat 
KBILD_revised_final 290419.docFile embargoed until 26 June 2020279.5 kBMicrosoft Word    Request a copy
Title: Kings brief interstitial lung disease questionnaire: Responsiveness and minimum clinically important difference
Authors: Nolan, CM
Birring, SS
Maddocks, M
Maher, TM
Patel, S
Barker, RE
Jones, SE
Walsh, JA
Wynne, SC
George, PM
Man, WD-C
Item Type: Journal Article
Abstract: Health status is increasingly used in clinical practice to quantify symptom burden and as a clinical trial endpoint in patients with interstitial lung disease (ILD). The Kings Brief Interstitial Lung Disease (KBILD) questionnaire is a brief validated 15-item, disease-specific, health-related quality of life questionnaire that is increasingly used in clinical trials, but little data exist regarding the minimum clinically important difference (MCID). Using pulmonary rehabilitation as a model, we aimed to determine responsiveness of the KBILD and provide estimates of the MCID.KBILD, Chronic Respiratory Questionnaire (CRQ), Medical Research Council dyspnoea scale (MRC) and incremental shuttle walk test (ISW) were measured in 209 patients with ILD (105 with idiopathic pulmonary fibrosis (IPF)) before and after an outpatient pulmonary rehabilitation programme. Changes with intervention and Cohen's effect size were calculated. Anchor- (linear regression and Receiver Operating Characteristic plots) or distribution-based approaches (0.5 * standard deviation, standard error of measurement) were used to estimate the MCID of KBILD domain and total scores.KBILD, CRQ, MRC and ISW improved with intervention and the effect sizes of KBILD domain and total scores ranged from 0.28 to 0.38. Using anchor-based estimates, the MCID estimate for KBILD-Psychological, KBILD-Breathlessness and activities and KBILD-Total score were 5.4, 4.4 and 3.9 respectively. Using distribution-based methods, the MCID estimate for KBILD-Chest symptoms was 9.8. The MCID estimates for KBILD in IPF patients were similar.In patients with ILD and IPF, KBILD is responsive to intervention with an estimated MCID of 3.9 for the total score.
Issue Date: 20-Jun-2019
Date of Acceptance: 1-Jun-2019
URI: http://hdl.handle.net/10044/1/71163
DOI: https://doi.org/10.1183/13993003.00281-2019
ISSN: 0903-1936
Publisher: European Respiratory Society
Journal / Book Title: European Respiratory Journal
Copyright Statement: © 2019 ERS
Keywords: 11 Medical and Health Sciences
Respiratory System
Publication Status: Published online
Conference Place: England
Embargo Date: 2020-06-26
Article Number: 1900281
Online Publication Date: 2019-06-20
Appears in Collections:National Heart and Lung Institute



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons